Erratum: The identity of innate immune activators in organ transplantation: Origins from within or exterior to the host? (American Journal of Transplantation (2007) 7, (1692-1694) DOI: 10.1111/j.1600-6143.2007.01851.x);The identity of innate immune activators in organ transplantation: Origins from within or exterior to the host?

American Journal of Transplantation

Volumn 7, Issue 7, 2007, Pages 1692-1694

  Goldstein, D R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cell; Innate immunity

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR 4;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL STUDY; EXPERIMENTAL STUDY; GRAFT REJECTION; INNATE IMMUNITY; LIVER ISCHEMIA; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 34250164226     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01907.x     Document Type: Erratum

References (34)

1. Obhrai J, Goldstein DR. The role of toll-like receptors in solid organ transplantation. Transplantation 2006 81 : 497 502.
2. Goldstein DR. Toll like receptors and the link between innate and acquire alloimmunity. Curr Opin Immunol 2004 16 : 538 544.
3. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol 2004 5 : 987 95.
4. Thornley TB, Brehm MA, Markees TG et al. TLR Agonists Abrogate Costimulation Blockade-Induced Prolongation of Skin Allografts. J Immunol 2006 176 : 1561 1570.
5. Chen L, Wang T, Zhou P et al. TLR engagment prevents transplantation tolerance. Am J Transplant 2007 6 : 2282 2291.
6. Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR. Absence of Innate MyD88 signaling promotes inducible allograft acceptance. J Immunol 2006 177 : 5307 5316.
7. Goldstein DR, Tesar BM, Akira S, Lakkis FG. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J Clin Invest 2003 111 : 1571 1578.
8. Pockley AG. Heat shock proteins, anti-heat shock protein reactivity and allograft rejection. Transplantation 2001 71 : 1503 1507.
9. Rock KL, Hearn A, Chen CJ, Shi Y. Natural endogenous adjuvants. Springer Semin Immunopathol 2005 26 : 231 246.
10. Bingaman AW, Ha J, Waitze S-Y et al. Vigorous allograft rejection in the absence of danger. J Immunol 2000 164 : 3065 3071.
11. Wells A, Larsson E, Hanas E, Laurent T, Hallgren R, Tufveson G. Increased hyaluronan in acutely rejecting human kidney grafts. Transplantation 1993 55 : 1346 1349.
12. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 2002 168 : 5233 5239.
13. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001 167 : 2887 2894.
14. Termeer C, Benedix F, Sleeman J et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002 195 : 99 111.
15. Tesar BM, Jiang D, Liang J, Palmer SM, Noble PW, Goldstein DR. The role of hyaluronan degradation products as innate alloimmune agonists. Am J Transplant 2006 6 : 2622 2635.
16. Ohashi K, Burkart V, Flohe S, Kolb H. Cutting edge: Heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000 164 : 558 561.
17. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006 6 : 823 835.
18. Helena Erlandsson Harris UA. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator. E J Immunol 2004 34 : 1503 1512.
19. Wang H, Bloom O, Zhang M et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999 285 : 248 251.
20. Lotze MT, Tracey KJ. High-mobility group box 1 protein (hmgb1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 2005 5 : 331 342.
21. Yang H, Ochani M, Li J et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. PNAS%R 10.1073/pnas. 2434651100 2004 101 : 296 301.
22. Tsung A, Sahai R, Tanaka H et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med 2005 201 : 1135 1143.
23. Tsung A, Hoffman RA, Izuishi K et al. Hepatic ischemia/reperfusion injury involves functional tlr4 signaling in nonparenchymal cells. J Immunol 2005 175 : 7661 7668.
24. Izuishi K, Tsung A, Jeyabalan G et al. Cutting edge: High-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 2006 176 : 7154 7158.
25. Park JS, Svetkauskaite D, He Q et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004 279 : 7370 7377.
26. Lin L. RAGE on the toll road. Cell Mol Immunol 2006 5 : 351 358.
27. Bierhaus A, Stern DM, PP. N. RAGE in inflammation: A new therapeutic target? Curr Opin Investig Drugs 2006 11 : 985 991.
28. Huang Y, Yin H, Han J et al. Extracellular Hmgb1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am J Transplant 2007 7 : 799 808.
29. Moser B, Szabolcs MJ, Ankersmit HJ et al. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am J Transplant 2007 7 : 293 302.
30. Gabriel R, Selwyn S, Brown D et al. Virus infections and acute renal transplant rejection. Nephron 1976 16 : 282 286.
31. Adams AB, Williams MA, Jones TR et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003 111 : 1887 1895.
32. Smith C, Pilgrim H, Steinmuller D. The survival of skin allografts and xenografts in germ-free mice. Transplantation 1972 13 : 38 41.
33. Jones ND, Turvey SE, Van Maurik A et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001 166 : 2824 2830.
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004 118 : 229.